Building the next generation of science-led consumer and clinical brands.
Veos Pharmaceuticals Secures Innowwide Call 4 / Eureka Funding to Bring BioPropello™ to Japan
Veos Pharmaceuticals has secured funding under the Innowwide Call 4 programme of the Eureka Network for BIOPRO-JP (ref. 2025-25398), ...
Read the announcement